58 related articles for article (PubMed ID: 8411105)
1. Dynamics of the immune system response in cerebrospinal fluid and blood of SIVmac-infected rhesus monkeys.
Sopper S; Hemm S; Meixensberger J; Coulibaly C; Stahl-Hennig C; Hunsmann G; Fleckenstein B; ter Meulen V; Dörries R
J Med Primatol; 1993; 22(2-3):138-46. PubMed ID: 8411105
[TBL] [Abstract][Full Text] [Related]
2. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
Smith MO; Heyes MP; Lackner AA
Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
[TBL] [Abstract][Full Text] [Related]
3. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
4. Emergence of antigenic variants of simian immunodeficiency virus (SIVmac) in a seronegative macaque after SIVmac239 infection.
Chuang LF; Blackbourn DJ; Chuang AJ; Killam KF; Liu X; Li Y; Kung HF; Chuang RY
Cell Mol Biol Res; 1994; 40(7-8):661-9. PubMed ID: 7787884
[TBL] [Abstract][Full Text] [Related]
5. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
[TBL] [Abstract][Full Text] [Related]
6. Neutralization/enhancement of macrophage-tropic SIVmac infection by plasma from macaques infected with macrophage-tropic or lymphocyte-tropic SIVmac.
Jolly PE; Huang L; Chen S
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):997-1008. PubMed ID: 11785666
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal synthesis of IgG in simian immunodeficiency virus (SIV)-infected rhesus macaques (Macaca mulatta).
Smith MO; Sutjipto S; Lackner AA
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):81-9. PubMed ID: 8179966
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B
Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868
[TBL] [Abstract][Full Text] [Related]
9. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
10. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa.
Murphey-Corb M; Wilson LA; Trichel AM; Roberts DE; Xu K; Ohkawa S; Woodson B; Bohm R; Blanchard J
J Immunol; 1999 Jan; 162(1):540-9. PubMed ID: 9886431
[TBL] [Abstract][Full Text] [Related]
12. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
13. Functional simian immunodeficiency virus Gag-specific CD8+ intraepithelial lymphocytes in the mucosae of SIVmac251- or simian-human immunodeficiency virus KU2-infected macaques.
Stevceva L; Moniuszko M; Alvarez X; Lackner AA; Franchini G
Virology; 2004 Feb; 319(2):190-200. PubMed ID: 14980480
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.
Abdel-Motal UM; Gillis J; Manson K; Wyand M; Montefiori D; Stefano-Cole K; Montelaro RC; Altman JD; Johnson RP
Virology; 2005 Mar; 333(2):226-38. PubMed ID: 15721357
[TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
[TBL] [Abstract][Full Text] [Related]
16. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
Uberla K; Rosenwirth B; Ten Haaft P; Heeney J; Sutter G; Erfle V
J Med Primatol; 2007 Feb; 36(1):2-9. PubMed ID: 17359459
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys.
Pauza CD; Emau P; Salvato MS; Trivedi P; MacKenzie D; Malkovsky M; Uno H; Schultz KT
J Med Primatol; 1993; 22(2-3):154-61. PubMed ID: 8411107
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.
Reimann KA; Tenner-Racz K; Racz P; Montefiori DC; Yasutomi Y; Lin W; Ransil BJ; Letvin NL
J Virol; 1994 Apr; 68(4):2362-70. PubMed ID: 8139022
[TBL] [Abstract][Full Text] [Related]
20. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.
Haigwood NL; Montefiori DC; Sutton WF; McClure J; Watson AJ; Voss G; Hirsch VM; Richardson BA; Letvin NL; Hu SL; Johnson PR
J Virol; 2004 Jun; 78(11):5983-95. PubMed ID: 15140996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
